The gadolinium market in Spain is expected to grow at a CAGR of 3.9% by 2034. Spain's leadership in medical tourism is supported by a reputable private healthcare sector, which attracts advanced ...

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

SAN FRANCISCO-- Action star Chuck Norris took on medical device manufacturers in a lawsuit filed in California on Wednesday alleging a chemical used in MRI imaging scans poisoned his wife. Gadolinium ...

MERIDIAN, ID, UNITED STATES, February 11, 2026 /EINPresswire.com/ -- Raising Awareness, Educating Communities, and ...

After a nearly 2-year study, the US Food and Drug Administration (FDA) has not found any evidence of adverse events from the brain's retention of gadolinium after MRI that uses gadolinium-based ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

A small but concerning number of women are exposed to a commonly used MRI contrast agent early in their pregnancy, likely before many of them are aware that they're pregnant, according to a study ...

Some of these studies evaluated GBCA use for durations >1 year and showed that gadolinium is retained in organs such as the brain, bones, and skin. After evaluating the risk of brain deposits with ...

A new study has shown that artificial intelligence could be used to dramatically reduce the amount of gadolinium used in MRI scans. The findings, which are being presented today at the annual meeting ...

Marignac first isolated gadolinia, an oxide of gadolinium (Gd), in 1880. Then, in 1886, Lecoq de Boisbaudran successfully separated the element from Mosander’s “yttria.” Gadolinium is present in ...